Insider at Oncology Institute (TOI) buys 27,429 company shares

Rhea-AI Filing Summary

Oncology Institute, Inc. ten percent owner Jorey Chernett reported an open-market purchase of 27,429 shares of Common Stock at a price of $2.96 per share. Following this transaction, he directly owns 10,479,358 common shares, indicating a modest increase to an already large position.

Insider Trade Summary

Net Buyer: 27,429 shares ($81,190)

Net Buy 1 txn

Insider Chernett Jorey

Role 10% Owner

Bought 27,429 shs ($81K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	27,429	$2.96	$81K

Holdings After Transaction: Common Stock — 10,479,358 shares (Direct)

Footnotes (1)

Key Figures

Shares purchased: 27,429 shares Purchase price: $2.96 per share Shares owned after transaction: 10,479,358 shares

3 metrics

Shares purchased 27,429 shares Open-market purchase of Common Stock

Purchase price $2.96 per share Price paid in the reported transaction

Shares owned after transaction 10,479,358 shares Direct common stock holdings following purchase

Key Terms

open-market purchase, ten percent owner, Common Stock

3 terms

open-market purchase financial

"classified as an open-market purchase of 27,429 shares at $2.96"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner financial

"ten percent owner Jorey Chernett reported an open-market purchase"

Common Stock financial

"purchase of 27,429 shares of Common Stock at a price of $2.96"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/27/2026		P		27,429	A	$2.96	10,479,358	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jorey Chernett	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TOI report for Jorey Chernett?

Oncology Institute, Inc. reported that ten percent owner Jorey Chernett completed an open-market purchase of 27,429 shares of Common Stock at $2.96 per share, modestly increasing his direct ownership stake in the company.

How many TOI shares does Jorey Chernett own after this Form 4?

After the reported transaction, Jorey Chernett directly owns 10,479,358 shares of Oncology Institute, Inc. common stock. This figure reflects his position immediately following the 27,429-share open-market purchase disclosed in the Form 4 filing.

Was the TOI insider transaction a buy or a sell?

The transaction was a buy. The Form 4 classifies it as an open-market purchase, with Jorey Chernett acquiring 27,429 shares of Oncology Institute, Inc. common stock rather than disposing of existing holdings.

At what price were the TOI shares purchased in this insider trade?

The shares were purchased at $2.96 per share. The Form 4 specifies this transaction price for the 27,429 Oncology Institute, Inc. common shares acquired in the open-market purchase by ten percent owner Jorey Chernett.

What type of security was involved in Jorey Chernett’s TOI transaction?

The transaction involved Oncology Institute, Inc. Common Stock. The Form 4 identifies the security title as Common Stock and records the acquisition of 27,429 shares in an open-market purchase.